- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/867 - Retroviral vectors
Patent holdings for IPC class C12N 15/867
Total number of patents in this class: 1399
10-year publication summary
|
33
|
90
|
79
|
82
|
88
|
81
|
105
|
132
|
110
|
93
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20268 |
23 |
| University Health Network | 1052 |
19 |
| The Children's Hospital of Philadelphia | 809 |
15 |
| Institut Pasteur | 783 |
15 |
| Shanghai Unicar-therapy Bio-medicine Technology Co., Ltd | 24 |
15 |
| Beijing Meikang Geno-immune Biotechnology Co., Ltd. | 24 |
15 |
| Oxford Biomedica (UK) Limited | 57 |
14 |
| Theravectys | 60 |
14 |
| Ospedale San Raffaele S.r.l. | 296 |
13 |
| The Trustees of the University of Pennsylvania | 4376 |
11 |
| American Gene Technologies International Inc. | 93 |
11 |
| Shenzhen Institutes of Advanced Technology | 1501 |
11 |
| Centre National de La Recherche Scientifique | 10666 |
10 |
| Nanjing Bioheng Biotech Co., Ltd | 46 |
10 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
9 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2903 |
9 |
| Shanghai NK Cell Tech Co., Ltd. | 20 |
9 |
| Genetix Biotherapeutics Inc. | 22 |
9 |
| Tsinghua University | 6011 |
8 |
| Autolus Limited | 260 |
8 |
| Other owners | 1151 |